phloroglucinol has been researched along with Parkinson Disease, Secondary in 2 studies
Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ryu, J | 1 |
| Zhang, R | 1 |
| Hong, BH | 1 |
| Yang, EJ | 1 |
| Kang, KA | 1 |
| Choi, M | 1 |
| Kim, KC | 1 |
| Noh, SJ | 1 |
| Kim, HS | 2 |
| Lee, NH | 1 |
| Hyun, JW | 1 |
| Wang, YD | 1 |
| Bao, XQ | 1 |
| Xu, S | 1 |
| Yu, WW | 1 |
| Cao, SN | 1 |
| Hu, JP | 1 |
| Li, Y | 1 |
| Wang, XL | 1 |
| Zhang, D | 1 |
| Yu, SS | 1 |
2 other studies available for phloroglucinol and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Phloroglucinol attenuates motor functional deficits in an animal model of Parkinson's disease by enhancing Nrf2 activity.
Topics: Animals; Antiparkinson Agents; Catalase; Cell Line; Gene Expression; Glutathione Peroxidase; Guanine | 2013 |
A Novel Parkinson's Disease Drug Candidate with Potent Anti-neuroinflammatory Effects through the Src Signaling Pathway.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Disease Models, Ani | 2016 |